Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 17, 2017

Study Completion Date

January 13, 2021

Conditions

Non-small Cell Lung CancerProgression of Non-small Cell Lung CancerNon-small Cell Lung Cancer Recurrent

Interventions

DRUG

Docetaxel

BIOLOGICAL

Tergenpumatucel-L

DRUG

Indoximod

Trial Locations (2)

University of Cincinnati, Cincinnati

Washington University in St. Louis, St Louis